MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer-Reference-Cited by-同舟云学术

MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer

Published:2015-07-22 Issue:5 Volume:48 Page:503-510
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif.

Author:

Yu Xin¹,Li Zheng¹,Yu Jun²,Chan Matthew T. V.³,Wu William K. K.²³

Affiliation:

1. Department of Orthopaedic Surgery; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing 100042 China

2. State-Key Laboratory of Digestive Diseases; LKS Institute of Health Sciences and Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Hong Kong 999077 China

3. Department of Anaesthesia and Intensive Care; The Chinese University of Hong Kong; Hong Kong 999077 China

Funder

The National Natural Science Foundation of China (NSFC)

Publisher

Wiley

Subject

Cell Biology,General Medicine

Reference86 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Increasing incidence of colorectal cancer in Asia: implications for screening;Sung;Lancet Oncol.,2005

3. A systematic review of treatment guidelines for metastatic colorectal cancer;Edwards;Colorectal Dis.,2012

4. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study;Cutsem;Ann. Oncol.,2009

5. Methods of overcoming treatment resistance in colorectal cancer;Temraz;Crit. Rev. Oncol. Hematol.,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil;Heliyon;2023-11

2. MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening—A Comprehensive Review;International Journal of Molecular Sciences;2023-07-03

3. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients With Stage IV Colorectal Cancer After Surgery;Diseases of the Colon & Rectum;2023-03-09

4. Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma;Non-coding RNA Research;2022-12

5. MicroRNAs and ‘Sponging’ Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets;International Journal of Molecular Sciences;2022-02-16